Gene expression profiles reveal distinct immunological responses of cobalt and cerium dioxide nanoparticles in two in vitro lung epithelial cell models

Toxicology Letters

Volumn 228, Issue 3, 2014, Pages 157-169

  Verstraelen, Sandra ^a   Remy, Sylvie ^a   Casals, Eudald ^b   De Boever, Patrick ^a,d   Witters, Hilda ^a   Gatti, Antonietta ^c   Puntes, Victor ^b   Nelissen, Inge ^a  

^a FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^b CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d HASSELT UNIVERSITY   (Belgium)

Author keywords

A549; BEAS 2B; Cerium dioxide; Cobalt oxide; Nanoparticles; Transcriptomics

Indexed keywords

CERIUM OXIDE; COBALT; NANOPARTICLE;

ARTICLE; CELL KINETICS; CELL TYPE; CELL VIABILITY; COMPARATIVE STUDY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; MARKER GENE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RNA ISOLATION; SCANNING TRANSMISSION ELECTRON MICROSCOPY; TOXIC INHALATION; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

A549; BEAS-2B; CERIUM DIOXIDE; COBALT OXIDE; NANOPARTICLES; TRANSCRIPTOMICS;

CELL LINE, TUMOR; CELL SURVIVAL; CERIUM; CLUSTER ANALYSIS; COBALT; COMPUTATIONAL BIOLOGY; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; KINETICS; LUNG; METAL NANOPARTICLES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDES; TRANSCRIPTION, GENETIC;

EID: 84901625062     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.05.006     Document Type: Article

References (52)

1. Puntes VF, Krishnan KM, Alivisatos AP. Colloidal nanocrystal shape and size control: the case of cobalt. Science 16-3-2001;291:2115-2117.
2. Cassee F.R., van Balen E.C., Singh C., Green D., Muijser H., Weinstein J., Dreher K. Exposure, health and ecological effects review of engineered nanoscale cerium and cerium oxide associated with its use as a fuel additive. Crit Rev Toxicol 2011, 41:213-229.
3. Hendren C.O., Mesnard X., Droge J., Wiesner M.R. Estimating Production Data for Five Engineered Nanomaterials As a Basis for Exposure Assessment. Environmental Sciene and Technology 2011, 45:2562-2569.
4. OECD. OECD Environment, Health and Savety Publications, Series on the Safety of manufactured Nanomaterials, Document No.6, List of Manufactured Nanomaterials and List of Endpoints for Phase One of the OECD Testing Programme. ENV/JM/MONO(2010)46/REV. 2010.
5. Lambrecht BN, Hammad H. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 4-9-2010;376:835-843.
6. Verstraelen S., Bloemen K., Nelissen I., Witters H., Schoeters G., Van Den Heuvel R. Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol In Vitro 2008, 22:1419-1431.
7. Petrarca C., Perrone A., Verna N., Verginelli F., Ponti J., Sabbioni E., Di G.L., Dadorante V., Schiavone C., Boscolo P., Mariani C.R., Di G.M. Cobalt nano-particles modulate cytokine in vitro release by human mononuclear cells mimicking autoimmune disease. Int J Immunopathol Pharmacol 2006, 19:11-14.
8. Yoon H.K., Moon H.S., Park S.H., Song J.S., Lim Y., Kohyama N. Dendriform pulmonary ossification in patient with rare earth pneumoconiosis. Thorax 2005, 60:701-703.
9. McDonald J.W., Ghio A.J., Sheehan C.E., Bernhardt P.F., Roggli V.L. Rare earth (cerium oxide) pneumoconiosis: analytical scanning electron microscopy and literature review. Mod Pathol 1995, 8:859-865.
10. Ma J.Y., Zhao H., Mercer R.R., Barger M., Rao M., Meighan T., Schwegler-Berry D., Castranova V., Ma J.K. Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology 2011, 5:312-325.
11. Srinivas A, Rao PJ, Selvam G, Murthy PB, Reddy PN. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett 28-8-2011;205:105-115.
12. Kim I.S., Baek M., Choi S.J. Comparative cytotoxicity of Al2O3, CeO2, TiO2 and ZnO nanoparticles to human lung cells. J Nanosci Nanotechnol 2010, 10:3453-3458.
13. Lin W., Huang Y.W., Zhou X.D., Ma Y. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 2006, 25:451-457.
14. Park EJ, Choi J, Park YK, Park K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 12-3-2008;245:90-100.
15. Eom HJ, Choi J. Oxidative stress of CeO2 nanoparticles via p38-Nrf-2 signaling pathway in human bronchial epithelial cell, Beas-2B. Toxicol Lett 1-6-2009;187:77-83.
16. Karakoti AS, Monteiro-Riviere NA, Aggarwal R, Davis JP, Narayan RJ, Self WT, McGinnis J, Seal S. Nanoceria as Antioxidant: Synthesis and Biomedical Applications. JOM (1989) 1-3-2008;60:33-37.
17. Schubert D, Dargusch R, Raitano J, Chan SW. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 31-3-2006;342:86-91.
18. Veranth J.M., Kaser E.G., Veranth M.M., Koch M., Yost G.S. Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part Fibre Toxicol 2007, 4:2.
19. Barillet S, Jugan ML, Laye M, Leconte Y, Herlin-Boime N, Reynaud C, Carriere M. In vitro evaluation of SiC nanoparticles impact on A549 pulmonary cells: cyto-, genotoxicity and oxidative stress. Toxicol Lett 20-10-2010;198:324-330.
20. Baber O., Jang M., Barber D., Powers K. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro BEAS-2B cells. Inhal Toxicol 2011, 23:532-543.
21. Eom H.J., Choi J. SiO(2) Nanoparticles Induced Cytotoxicity by Oxidative Stress in Human Bronchial Epithelial Cell, Beas-2B. Environ Health Toxicol 2011, 26:e2011013.
22. Panas A, Marquardt C, Nalcaci O, Bockhorn H, Baumann W, Paur HR, Mulhopt S, Diabate S, Weiss C. Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages. Nanotoxicology 26-1-2012;7:259-273.
23. Euliss L.E., Grancharov S.G., O'Brien S., Deming T.J., Stucky G.D., Murray C.B., Held G.A. Cooperative Assembly of magnetic nanoparticles and block popolypeptides in aqueous media. Nano Letters 2003, 3.
24. Chen H-I., Chang H-Y. Synthesis and characterization of nanocrystalline cerium oxide powders by two-stage non-isothermal precipitation. Solid State Communications 2005, 133:593-598.
25. Zhou X-D., Huebner W., Anderson H.U. Room-temperature homogeneous nucleation synthesis and thermal stability of nanometer single crystal CeO2. Applied Physics Letters 2002, 80:3814-3816.
26. Tong W., Cao X., Harris S., Sun H., Fang H., Fuscoe J., Harris A., Hong H., Xie Q., Perkins R., Shi L., Casciano D. ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect 2003, 111:1819-1826.
27. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes VF. Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. Small 16-12-2011;7:3479-3486.
28. Oostingh G.J., Casals E., Italiani P., Colognato R., Stritzinger R., Ponti J., Pfaller T., Kohl Y., Ooms D., Favilli F., Leppens H., Lucchesi D., Rossi F., Nelissen I., Thielecke H., Puntes V.F., Duschl A., Boraschi D. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part Fibre Toxicol 2011, 8:8.
29. Tuomela S., Autio R., Buerki-Thurnherr T., Arslan O., Kunzmann A., Andersson-Willman B., Wick P., Mathur S., Scheynius A., Krug H.F., Fadeel B., Lahesmaa R. Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One 2013, 8:e68415.
30. Ge Y., Bruno M., Wallace K., Winnik W., Prasad R.Y. Proteome profiling reveals potential toxicity and detoxification pathways following exposure of BEAS-2B cells to engineered nanoparticle titanium dioxide. Proteomics 2011, 11:2406-2422.
31. Foldbjerg R., Irving E.S., Hayashi Y., Sutherland D.S., Thorsen K., Autrup H., Beer C. Global gene expression profiling of human lung epithelial cells after exposure to nanosilver. Toxicol Sci 2012, 130:145-157.
32. Wilkinson K, Ekstrand-Hammarstrom B, Ahlinder L, Guldevall K, Pazik R, Kepinski L, Kvashnina KO, Butorin SM, Brismar H, Onfelt B, Osterlund L, Seisenbaeva GA, Kessler VG. Visualization of custom-tailored iron oxide nanoparticles chemistry, uptake, and toxicity. Nanoscale 7-12-2012;4:7383-7393.
33. Cronholm P, Karlsson HL, Hedberg J, Lowe TA, Winnberg L, Elihn K, Wallinder IO, Moller L: Intracellular Uptake and Toxicity of Ag and CuO Nanoparticles: A Comparison Between Nanoparticles and their Corresponding Metal Ions. Small 7-1-2013;8:970-982.
34. Foldbjerg R, Wang J, Beer C, Thorsen K, Sutherland DS, Autrup H. Biological effects induced by BSA-stabilized silica nanoparticles in mammalian cell lines. Chem Biol Interact 25-6-2013;204:28-38.
35. Gualtieri M., Ovrevik J., Holme J.A., Perrone M.G., Bolzacchini E., Schwarze P.E., Camatini M. Differences in cytotoxicity versus pro-inflammatory potency of different PM fractions in human epithelial lung cells. Toxicol In Vitro 2010, 24:29-39.
36. Ovrevik J, Lag M, Holme JA, Schwarze PE, Refsnes M. Cytokine and chemokine expression patterns in lung epithelial cells exposed to components characteristic of particulate air pollution. Toxicology 2-5-2009;259:46-53.
37. Paur H.R., Cassee F.R., Teeguarden J., Fissan H., Diabate S., Aufderheide M., Kreyling W.G., H+ñnninen O., Kasper G., Riediker M., Rothen-Rutishauser B., Schmid O. In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lungΓÇöA dialog between aerosol science and biology. Journal of Aerosol Science 2011, 42:668-692.
38. Volckens J, Dailey L, Walters G, Devlin RB. Direct particle-to-cell deposition of coarse ambient particulate matter increases the production of inflammatory mediators from cultured human airway epithelial cells. Environ Sci Technol 15-6-2009;43:4595-4599.
39. Grass R.N., Limbach L.K., Athanassiou E.K., Stark W.J. Exposure of aerosols and nanoparticle dispersions to in vitro cell cultures: a review o nthe dose relevance of size, mass, surface and concentration. Journal of Aerosol Science 2010, 41:1123-1142.
40. Verstraelen S, Nelissen I, Hooyberghs J, Witters H, Schoeters G, Van CP, Van Den Heuvel R. Gene profiles of a human bronchial epithelial cell line after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicology 31-1-2009;255:151-159.
41. Luyts K., Napierska D., Nemery B., Hoet P.H.M. How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrealtions. Environ Sci: Processes Impacts 2013, 15:23-38.
42. Moos P.J., Olszewski K., Honeggar M., Cassidy P., Leachman S., Woessner D., Cutler N.S., Veranth J.M. Responses of human cells to ZnO nanoparticles: a gene transcription study. Metallomics 2011, 3:1199-1211.
43. Johnston H.J., Hutchison G.R., Christensen F.M., Peters S., Hankin S., Stone V. Identification of the mechanisms that drive the toxicity of TiO(2)particulates: the contribution of physicochemical characteristics. Part Fibre Toxicol 2009, 6:33.
44. Goto E., Kohrogi H., Hirata N., Tsumori K., Hirosako S., Hamamoto J., Fujii K., Kawano O., Ando M. Human bronchial intraepithelial T lymphocytes as a distinct T-cell subset: their long-term survival in SCID-Hu chimeras. Am J Respir Cell Mol Biol 2000, 22:405-411.
45. Rate A, Upham WJ. The Pulmonary Epithelium in Health and Disease: The Epithelium and Immunoregulation; in 2008.
46. Gereke M, Jung S, Buer J, Bruder D. Alveolar type II epithelial cells present antigen to CD4(+) T cells and induce Foxp3(+) regulatory T cells. Am J Respir Crit Care Med 1-3-2009;179:344-355.
47. Jeyaseelan S, Manzer R, Young SK, Yamamoto M, Akira S, Mason RJ, Worthen GS. Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against Escherichia coli lipopolysaccharide and viable Escherichia coli. J Immunol 1-12-2005;175:7484-7495.
48. Bengalli R., Molteni E., Longhin E., Refsnes M., Camatini M., Gualtieri M. Release of IL-1 beta Triggered by Milan Summer PM10: Molecular Pathways Involved in the Cytokine Release. BioMed Research International 2013, 1-9.
49. Moreira A.P., Cavassani K.A., Ismailoglu U.B., Hullinger R., Dunleavy M.P., Knight D.A., Kunkel S.L., Uematsu S., Akira S., Hogaboam C.M. The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J Clin Invest 2011, 121:4420-4432.
50. Jang S., Park J.W., Cha H.R., Jung S.Y., Lee J.E., Jung S.S., Kim J.O., Kim S.Y., Lee C.S., Park H.S. Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation. Int J Nanomedicine 2012, 7:1329-1343.
51. Watterson T.L., Hamilton B., Martin R.S., Coulombe R.A. Urban particulate matter activates Akt in human lung cells. Arch Toxicol 2012, 86:121-135.
52. Omidi Y., Barar J. Induction of human alveolar epithelial cell growth factor receptors by dendrimeric nanostructures. Int J Toxicol 2009, 28:113-122.